Management and outcomes of real-world use of non-vitamin-K oral anticoagulants (NOACs) in patients with atrial fibrillation: experience of a dedicated NOAC clinic

BACKGROUND: Current guidelines recommend non-vitamin‑K oral anticoagulants (NOACs) as the first-choice therapy for stroke prevention in patients with atrial fibrillation (AF). The use of drugs in a clinical trial setting differs from that in real-world populations. Real-world data are important to a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neth Heart J
Hlavní autoři: de Veer, A. J. W. M., Bennaghmouch, N., Wijffels, M. C. E. F., ten Berg, J. M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Bohn Stafleu van Loghum 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6890914/
https://ncbi.nlm.nih.gov/pubmed/31773474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-019-01330-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky